189 related articles for article (PubMed ID: 22722882)
1. Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.
Patton DE; Woods SP; Franklin D; Cattie JE; Heaton RK; Collier AC; Marra C; Clifford D; Gelman B; McArthur J; Morgello S; Simpson D; McCutchan JA; Grant I
AIDS Behav; 2012 Nov; 16(8):2286-96. PubMed ID: 22722882
[TBL] [Abstract][Full Text] [Related]
2. The impact of neuropsychological performance on everyday functioning between older and younger adults with and without HIV.
Vance DE; Fazeli PL; Gakumo CA
J Assoc Nurses AIDS Care; 2013; 24(2):112-25. PubMed ID: 22943982
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal change in cognitive function and medication adherence in HIV-infected adults.
Becker BW; Thames AD; Woo E; Castellon SA; Hinkin CH
AIDS Behav; 2011 Nov; 15(8):1888-94. PubMed ID: 21437726
[TBL] [Abstract][Full Text] [Related]
4. Construct validity of the UCSD performance-based skills assessment-brief version (UPSA-B) in HIV disease.
Sheppard DP; Woods SP; Verduzco M;
Appl Neuropsychol Adult; 2018; 25(6):543-554. PubMed ID: 28742398
[TBL] [Abstract][Full Text] [Related]
5. The Combined Roles of Nonsomatic Depressive Symptomatology, Neurocognitive Function, and Current Substance Use in Medication Adherence in Adults Living With HIV Infection.
Scott TM; Byrd D; Arce Rentería M; Coulehan K; Miranda C; Fuentes A; Rivera Mindt M
J Assoc Nurses AIDS Care; 2018; 29(2):178-189. PubMed ID: 28988793
[TBL] [Abstract][Full Text] [Related]
6. Intra-individual neurocognitive variability confers risk of dependence in activities of daily living among HIV-seropositive individuals without HIV-associated neurocognitive disorders.
Morgan EE; Woods SP; Grant I;
Arch Clin Neuropsychol; 2012 May; 27(3):293-303. PubMed ID: 22337933
[TBL] [Abstract][Full Text] [Related]
7. Depression and neurocognitive performance in Portuguese patients infected with HIV.
Bragança M; Palha A
AIDS Behav; 2011 Nov; 15(8):1879-87. PubMed ID: 21598031
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive profile of HIV-positive adults on combined antiretroviral therapy: A single-centre study in Serbia.
Malagurski B; Bugarski Ignjatović V; Marić D; Nikolašević Ž; Mihić L; Brkić S
Appl Neuropsychol Adult; 2018; 25(6):513-522. PubMed ID: 28665215
[TBL] [Abstract][Full Text] [Related]
11. Aging, neurocognition, and medication adherence in HIV infection.
Ettenhofer ML; Hinkin CH; Castellon SA; Durvasula R; Ullman J; Lam M; Myers H; Wright MJ; Foley J
Am J Geriatr Psychiatry; 2009 Apr; 17(4):281-90. PubMed ID: 19307857
[TBL] [Abstract][Full Text] [Related]
12. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
[TBL] [Abstract][Full Text] [Related]
13. A neuropsychological investigation of multitasking in HIV infection: implications for everyday functioning.
Scott JC; Woods SP; Vigil O; Heaton RK; Schweinsburg BC; Ellis RJ; Grant I; Marcotte TD;
Neuropsychology; 2011 Jul; 25(4):511-9. PubMed ID: 21401259
[TBL] [Abstract][Full Text] [Related]
14. A closer look at depression and its relationship to HIV antiretroviral adherence.
Wagner GJ; Goggin K; Remien RH; Rosen MI; Simoni J; Bangsberg DR; Liu H;
Ann Behav Med; 2011 Dec; 42(3):352-60. PubMed ID: 21818528
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.
Moore DJ; Blackstone K; Woods SP; Ellis RJ; Atkinson JH; Heaton RK; Grant I;
AIDS Care; 2012; 24(12):1504-13. PubMed ID: 22530794
[TBL] [Abstract][Full Text] [Related]
16. Risky decision-making in HIV-associated neurocognitive disorders (HAND).
Iudicello JE; Woods SP; Cattie JE; Doyle K; Grant I;
Clin Neuropsychol; 2013; 27(2):256-75. PubMed ID: 23181946
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.
Meade CS; Conn NA; Skalski LM; Safren SA
J Behav Med; 2011 Apr; 34(2):128-38. PubMed ID: 20857187
[TBL] [Abstract][Full Text] [Related]
18. Association Between Cognitive Tests and Antiretroviral Medication Adherence in Older Adults With HIV.
Caballero J; Ownby RL; Jacobs RJ; Thomas JE; Schweizer MS
Ann Pharmacother; 2019 Feb; 53(2):151-158. PubMed ID: 30175588
[TBL] [Abstract][Full Text] [Related]
19. Relationship of prospective memory to neuropsychological function and antiretroviral adherence.
Contardo C; Black AC; Beauvais J; Dieckhaus K; Rosen MI
Arch Clin Neuropsychol; 2009 Sep; 24(6):547-54. PubMed ID: 19648150
[TBL] [Abstract][Full Text] [Related]
20. Concordance Between Self-Report and Performance-Based Measures of Everyday Functioning in HIV-Associated Neurocognitive Disorders.
Shirazi TN; Summers AC; Smith BR; Steinbach SR; Kapetanovic S; Nath A; Snow J
AIDS Behav; 2017 Jul; 21(7):2124-2134. PubMed ID: 28108876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
